Dr Lalchandani Labs Ltd Fair Value
DLCL · Healthcare Services · Current price ₹7.64
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹15 | 4% ROE fading to 12% over ~3 yrs, on ₹16 book |
| Relative P/E | ₹97 | EPS × 67.8 peer-median P/E |
| Graham floor | ₹23 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | — | No analyst coverage |
Is Dr Lalchandani Labs Ltd undervalued?
DocStoX estimates the fair value of Dr Lalchandani Labs Ltd at ₹39 per share, versus the current market price of ₹8. That puts the stock about +414.6% below our fair-value estimate, which we read as "Expensive". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 3 independent methods: Residual income (₹15), Relative P/E (₹97), Graham floor (₹23). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹15 (bear) to ₹39 (base) to ₹97 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on Dr Lalchandani Labs Ltd
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.